Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Late-Breaking Data From PROMISE I Study on LimFlow System Confirm Excellent Sustained Outcomes In Patients With No-Option Chronic Limb-Threatening Ischemia
10/14/2021
Limb salvage in 77 percent of patients at 2 years with "no-option" for revascularization via traditional techniques.
Limb salvage in 77 percent of patients at 2 years with "no-option" for revascularization via traditional techniques.
Limb salvage in 77 percent of...
10/14/2021
Cath Lab Digest
News
BASHIR Endovascular Catheter Shows Marked Reduction in RV/LV Ratio and Thrombus Burden in Patients with Acute Intermediate Risk PE: Interim Results of NIH-Funded RESCUE Trial
10/13/2021
New Britain, PA, October 5, 2021 – THROMBOLEX, INC. today announced the results of the RESCUE Trial’s pre-specified interim analysis, of the first 62 evaluable patients, at a Late Breaking Clinical Trials session at the VIVA Conference in Las...
New Britain, PA, October 5, 2021 – THROMBOLEX, INC. today announced the results of the RESCUE Trial’s pre-specified interim analysis, of the first 62 evaluable patients, at a Late Breaking Clinical Trials session at the VIVA Conference in Las...
New Britain, PA, October 5, 2021...
10/13/2021
Vascular Disease Management
News
U.S. Preventive Services Task Force Issues Draft Recommendation Statement on Aspirin Use to Prevent Cardiovascular Disease
10/12/2021
People 40 to 59 should decide with their clinician whether to start taking aspirin; people 60 or older should not start taking aspirin   WASHINGTON, D.C. – October 12, 2021 – The U.S. Preventive Services Task Force (Task Force) posted a...
People 40 to 59 should decide with their clinician whether to start taking aspirin; people 60 or older should not start taking aspirin   WASHINGTON, D.C. – October 12, 2021 – The U.S. Preventive Services Task Force (Task Force) posted a...
People 40 to 59 should decide...
10/12/2021
Cath Lab Digest

Advertisement

News
VIVA: Clinical Data from INSIGHT Trial Demonstrate Safety and Efficacy of Pantheris for Treatment of In-Stent Restenosis
10/07/2021
Redwood City, Calif., October 7, 2021 - Avinger, Inc., a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease...
Redwood City, Calif., October 7, 2021 - Avinger, Inc., a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease...
Redwood City, Calif., October 7,...
10/07/2021
Cath Lab Digest
News
BD Announces 510(k) Clearance of Expanded Indications for the Rotarex Atherectomy System
10/07/2021
Rotarex™ Rotational Excisional Atherectomy System is the first and only atherectomy and thrombectomy device indicated to treat in-stent restenosis in the United States FRANKLIN LAKES, N.J., Oct. 6, 2021 — BD...
Rotarex™ Rotational Excisional Atherectomy System is the first and only atherectomy and thrombectomy device indicated to treat in-stent restenosis in the United States FRANKLIN LAKES, N.J., Oct. 6, 2021 — BD...
Rotarex™ Rotational Excisional...
10/07/2021
Cath Lab Digest
News
VIVA: Shockwave IVL Consistently Treats “Real World” Calcium Across Multiple Peripheral Vessel Beds
10/06/2021
Disrupt PAD III Observational Arm Confirms IVL Safely and Effectively Modifies Superficial and Deep Calcium in Complex Calcified Lesions LAS VEGAS, Nevada, October 6, 2021 -- Shockwave Medical, Inc., a pioneer in the development and...
Disrupt PAD III Observational Arm Confirms IVL Safely and Effectively Modifies Superficial and Deep Calcium in Complex Calcified Lesions LAS VEGAS, Nevada, October 6, 2021 -- Shockwave Medical, Inc., a pioneer in the development and...
Disrupt PAD III Observational...
10/06/2021
Cath Lab Digest

Advertisement

News
ReCor Medical Launches Paradise Ultrasound Renal Denervation for the Treatment of Hypertension in Europe
10/06/2021
Treatment Supported by Evidence from Multiple Studies and Renal Denervation Position Paper from the European Society of Hypertension October 06, 2021, PALO ALTO, Calif. & FRANKFURT, Germany — ReCor Medical, Inc., a wholly owned...
Treatment Supported by Evidence from Multiple Studies and Renal Denervation Position Paper from the European Society of Hypertension October 06, 2021, PALO ALTO, Calif. & FRANKFURT, Germany — ReCor Medical, Inc., a wholly owned...
Treatment Supported by Evidence...
10/06/2021
Cath Lab Digest
News
VIVA: Boston Scientific Eluvia Drug-Eluting Vascular Stent System Exhibits Superiority Compared to Bare Metal Stents
10/06/2021
Late-breaking data demonstrate superior rates of primary patency and statistically significant sustained clinical improvement LAS VEGAS and MARLBOROUGH, Mass., Oct. 6, 2021 — Boston Scientific Corporation announced positive data for the...
Late-breaking data demonstrate superior rates of primary patency and statistically significant sustained clinical improvement LAS VEGAS and MARLBOROUGH, Mass., Oct. 6, 2021 — Boston Scientific Corporation announced positive data for the...
Late-breaking data demonstrate...
10/06/2021
Cath Lab Digest
News
VIVA: Positive Late-Breaking Clinical Trial Data for the EkoSonic Endovascular System
10/06/2021
Analysis found no intracerebral hemorrhages, low major bleeding rates; registry represents largest data set in interventional treatment of pulmonary embolism LAS VEGAS and MARLBOROUGH, Mass., Oct. 6, 2021 — Boston Scientific...
Analysis found no intracerebral hemorrhages, low major bleeding rates; registry represents largest data set in interventional treatment of pulmonary embolism LAS VEGAS and MARLBOROUGH, Mass., Oct. 6, 2021 — Boston Scientific...
Analysis found no intracerebral...
10/06/2021
Cath Lab Digest

Advertisement

News
VIVA: Positive Late-Breaking Clinical Trial Data for Boston Scientific's Ranger Drug-Coated Balloon
10/06/2021
Two-year data demonstrate continued high rates of primary patency including in patients with complex lesions   LAS VEGAS and MARLBOROUGH, Mass., Oct. 6, 2021 — Boston Scientific announced positive results for the...
Two-year data demonstrate continued high rates of primary patency including in patients with complex lesions   LAS VEGAS and MARLBOROUGH, Mass., Oct. 6, 2021 — Boston Scientific announced positive results for the...
Two-year data demonstrate...
10/06/2021
Cath Lab Digest

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

Sleep and CVD
Study of Sleep in Women Shows Delaying Bedtime by Just 90 Minutes Each Night Damages Endothelial Cells
08/06/2024
After just six weeks of shortened sleep, the study found, the cells that line our blood vessels are flooded by damaging oxidants. And unlike well-rested cells, sleep-restricted cells fail to activate antioxidant responses to clear the...
After just six weeks of shortened sleep, the study found, the cells that line our blood vessels are flooded by damaging oxidants. And unlike well-rested cells, sleep-restricted cells fail to activate antioxidant responses to clear the...
After just six weeks of...
08/06/2024
Cath Lab Digest
Peripheral Interventions
VentureMed Completes Enrollment of the FLEX Vessel Prep System FLEX First AV Registry For The Treatment of Arteriovenous (AV) Access Management
07/30/2024
The FLEX Vessel Prep System has a unique non-balloon-based mechanism of action that creates longitudinal micro-incisions that release circumferential tension in diseased vessels. This release of tension is how FLEX modifies AV stenoses to...
The FLEX Vessel Prep System has a unique non-balloon-based mechanism of action that creates longitudinal micro-incisions that release circumferential tension in diseased vessels. This release of tension is how FLEX modifies AV stenoses to...
The FLEX Vessel Prep System has...
07/30/2024
Cath Lab Digest
Peripheral Interventions
Transit Scientific’s Novel XO Cath Microcatheter Breaks New Ground in Transradial Embolic Delivery Procedure
07/30/2024
​ Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, announced a milestone achievement with the successful utilization of XO Cath, its pioneering embolic delivery...
​ Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, announced a milestone achievement with the successful utilization of XO Cath, its pioneering embolic delivery...
​ Transit Scientific, a...
07/30/2024
Cath Lab Digest
Carotid Artery Revascularization
Silk Road Medical Celebrates Milestone of 100,000 Transcarotid Artery Revascularization (TCAR) Procedures
07/30/2024
Transcarotid Artery Revascularization (TCAR) is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a...
Transcarotid Artery Revascularization (TCAR) is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a...
Transcarotid Artery...
07/30/2024
Cath Lab Digest
Health Care Needs
JACC: Almost Half of U.S. Counties Have No Cardiologists Despite Higher Prevalence of CV Risk Factors, Mortality
07/29/2024
Upon analyzing all 3,143 U.S. counties, it was determined that 1,454 counties (46.3%) with 22 million residents had no cardiologists while the other 1,689 counties each had 24 cardiologists on average. 86.2% of rural counties had no...
Upon analyzing all 3,143 U.S. counties, it was determined that 1,454 counties (46.3%) with 22 million residents had no cardiologists while the other 1,689 counties each had 24 cardiologists on average. 86.2% of rural counties had no...
Upon analyzing all 3,143 U.S....
07/29/2024
Cath Lab Digest
Renal Denervation
First Patients Treated in Recor Medical’s Global Paradise System US Post Approval Study (US GPS) for the Treatment of Uncontrolled Hypertension With Ultrasound Renal Denervation
07/25/2024
The study will focus on gathering real-world safety and effectiveness data over five years from up to 1,000 patients, collaborating with research centers to help advance diversity and health equity within clinical trials. Building upon the...
The study will focus on gathering real-world safety and effectiveness data over five years from up to 1,000 patients, collaborating with research centers to help advance diversity and health equity within clinical trials. Building upon the...
The study will focus on...
07/25/2024
Cath Lab Digest
Ischemic Stroke
Imperative Care Announces Clinical Data from the Pivotal Imperative Trial Evaluating the Zoom Reperfusion System for the Treatment of Ischemic Stroke
07/24/2024
“The observed data showed all three pre-specified performance goals were met. These data suggest a lower rate of rescue therapy than prior thrombectomy trials and may demonstrate that intracranial positioning of a super-large bore catheter...
“The observed data showed all three pre-specified performance goals were met. These data suggest a lower rate of rescue therapy than prior thrombectomy trials and may demonstrate that intracranial positioning of a super-large bore catheter...
“The observed data showed all...
07/24/2024
Cath Lab Digest
LINC
News
HMP Global’s Leipzig Interventional Course (LINC) Announces 20th Anniversary Congress in January 2025
07/22/2024
LINC, the world’s premier interdisciplinary live course for vascular and endovascular teams, announced that its annual meeting is shifting from summer to winter, with its 20th anniversary Congress in January 2025.
LINC, the world’s premier interdisciplinary live course for vascular and endovascular teams, announced that its annual meeting is shifting from summer to winter, with its 20th anniversary Congress in January 2025.
LINC, the world’s premier...
07/22/2024
Vascular Disease Management
News
Life Seal Vascular Inc. Awarded Prestigious NSF SBIR Grant to Advance Innovative Endovascular Aortic Aneurysm Sac Management Technology
07/17/2024
More than $274,000 in NSF funding to develop breakthrough aneurysm sac management technology
More than $274,000 in NSF funding to develop breakthrough aneurysm sac management technology
More than $274,000 in NSF...
07/17/2024
Vascular Disease Management
Ischemic Stroke
Imperative Care Announces FDA Clearance and Initial Cases of the Zoom 6F Insert Catheters, the First Insert Catheters Built for Stroke
07/17/2024
Based on physician feedback, the new Zoom 6F Insert Catheters were developed to be more supportive, more torque-able and longer than current vessel selection devices and are offered in three stroke-specific shapes.
Based on physician feedback, the new Zoom 6F Insert Catheters were developed to be more supportive, more torque-able and longer than current vessel selection devices and are offered in three stroke-specific shapes.
Based on physician feedback, the...
07/17/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use